Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 10/20 | 0.52 |
| ▸ | PPARA | Q07869 | 8/20 | 0.52 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 4/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.37 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PTGES | O14684 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31370590 | 0.92 | PPARG (0.52) | PPARGPPARAITGB3ITGA2BALDH1A1 | |
| SCHEMBL16634664 | 0.89 | ITGB3 (0.54) | PPARGPPARAITGB3ITGA2BPPARD | |
| SCHEMBL29633734 | 0.88 | ITGB3 (0.45) | PPARGPPARAITGB3ITGA2B | |
| SCHEMBL8713900 | 0.88 | ITGB3 (0.45) | PPARGPPARAITGB3ITGA2B | |
| SCHEMBL29981783 | 0.88 | ITGB3 (0.45) | PPARGPPARAITGB3ITGA2B | |
| SCHEMBL25358372 | 0.88 | ITGB3 (0.45) | PPARGPPARAITGB3ITGA2B | |
| SCHEMBL6318711 | 0.88 | ITGB3 (0.45) | PPARGPPARAITGB3ITGA2B | |
| SCHEMBL25356274 | 0.88 | PPARG (0.43) | PPARGPPARAITGB3ITGA2BALDH1A1 | |
| SCHEMBL25356271 | 0.88 | PPARG (0.43) | PPARGPPARAITGB3ITGA2BALDH1A1 | |
| SCHEMBL120595 | 0.88 | ITGB3 (0.45) | PPARGPPARAITGB3ITGA2BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | PPARG 3591/4885PPARA 3450/4885ITGB3 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.